West Pharmaceutical Services (WST)
(Delayed Data from NYSE)
$360.43 USD
-7.75 (-2.10%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $360.42 -0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 7/25/24 |
---|---|
Current Quarter | 1.92 |
EPS Last Quarter | 1.56 |
Last EPS Surprise | 20.93% |
ABR | 1.57 |
Earnings ESP
|
-2.92% |
---|---|
Current Year | 7.65 |
Next Year | 9.14 |
EPS (TTM) | 7.66 |
P/E (F1) | 47.10 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 763.24M | 781.28M | 3.01B | 3.28B |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 765.40M | 786.70M | 3.02B | 3.32B |
Low Estimate | 761.95M | 778.74M | 3.01B | 3.26B |
Year ago Sales | 753.80M | 747.40M | 2.95B | 3.01B |
Year over Year Growth Est. | 1.25% | 4.53% | 2.12% | 8.83% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.92 | 2.15 | 7.65 | 9.14 |
# of Estimates | 5 | 4 | 6 | 6 |
Most Recent Consensus | 1.97 | 2.11 | 7.55 | 9.01 |
High Estimate | 2.04 | 2.19 | 7.89 | 9.39 |
Low Estimate | 1.68 | 2.10 | 7.55 | 9.00 |
Year ago EPS | 2.11 | 2.16 | 8.08 | 7.65 |
Year over Year Growth Est. | -9.00% | -0.46% | -5.32% | 19.38% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 1 | 2 | 1 |
Up Last 30 Days | 1 | 2 | 2 | 1 |
Up Last 60 Days | 1 | 2 | 2 | 2 |
Down Last 7 Days | 1 | 1 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 2 | 2 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 1.92 | 2.15 | 7.65 | 9.14 |
7 Days Ago | 2.00 | 2.13 | 7.62 | 9.12 |
30 Days Ago | 2.00 | 2.13 | 7.63 | 9.12 |
60 Days Ago | 2.07 | 2.14 | 7.95 | 9.20 |
90 Days Ago | 2.33 | 2.22 | 8.77 | 9.93 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.86 | 2.16 | 7.62 | 9.06 |
Zacks Consensus Estimate | 1.92 | 2.15 | 7.65 | 9.14 |
Earnings ESP | -2.92% | 0.66% | -0.49% | -0.83% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.56 | 1.83 | 2.16 | 2.11 | NA |
Estimate | 1.29 | 1.78 | 1.86 | 1.95 | NA |
Difference | 0.27 | 0.05 | 0.30 | 0.16 | 0.20 |
Surprise | 20.93% | 2.81% | 16.13% | 8.21% | 12.02% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more